Articles Tagged With:
-
Percutaneous Coronary Interventions in Nonagenarians
Nonagenarians can undergo percutaneous coronary interventions with low in-lab complication rates, but 30-day and one-year mortality is considerably higher than in younger patients.
-
Palliative Care-based Intervention Improves Quality of Life in Chronic Heart Failure
Among patients with advanced heart failure, implementation of an interdisciplinary palliative care intervention was associated with improved quality of life.
-
Advance Care Planning Must Advance Forward
In a systematic review of 795,909 people in 150 studies, researchers found many Americans have not completed an advance directive.
-
Secondary Heart Failure Affects Readmissions
Heart failure that develops or worsens during a hospital stay can affect outcomes, costs, and readmissions, so hospitals are advised to identify patients at risk for secondary heart failure.
-
Hartford Healthcare Launching Quality Initiatives
Hartford HealthCare, a healthcare network in Connecticut, is launching a series of quality initiatives aimed at getting patients the care they need quickly and safely.
-
Copy-and-Paste Continues to Threaten Documentation Safety
Copy-and-paste is so easy and time saving that it can be tempting to overuse it in the medical record, and some electronic medical records encourage clinicians to use blocks of text over and over. Liberal use of copy-and-paste can diminish the quality and reliability of an electronic medical record, however.
-
Staffing Grid Improves Satisfaction for Patients and Nurses, Reduces Falls
A new staffing grid focused on improving patient, nurse and staff satisfaction contributed to reducing patient falls by 50% and staff injuries by 81% over approximately one year at Sharp Memorial Hospital in San Diego.
-
Improved Patient Handoffs Require Comprehensive Approach
Hospitals are paying more attention to patient handoffs as a crucial element in quality and patient safety, with an evolution toward seeing them as not just a distinct task, but more as a comprehensive strategy.
-
Clinical Briefs
In this section: diagnosing pulmonary embolism; tackling early prostate cancer; and treating urinary tract symptoms.
-
Glecaprevir and Pibrentasvir Tablets (Mavyret)
The FDA has approved a dual fixed-dose combination of glecaprevir, a NS3/4A protease inhibitor, and pibrentasvir, a NS5A inhibitor, for the treatment of all major genotypes (1-6) of chronic hepatitis C infections.